These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31681594)

  • 1. MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.
    Niu M; Zhang N; Wang R; Shao T; Feng Y; Shen Y; Liu X; Zhao K; Zhu S; Xu L; Yao Y; Xu K
    Front Oncol; 2019; 9():1058. PubMed ID: 31681594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia.
    Niu M; Feng Y; Zhang N; Shao T; Zhang H; Wang R; Yao Y; Yao R; Wu Q; Cao J; Liu X; Liu Y; Xu K
    Cancer Cell Int; 2019; 19():122. PubMed ID: 31080363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
    Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
    J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
    Zhang H; Zhang N; Wang R; Shao T; Feng Y; Yao Y; Wu Q; Zhu S; Cao J; Zhang H; Li Z; Liu X; Niu M; Xu K
    J Transl Med; 2019 Apr; 17(1):106. PubMed ID: 30935386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-425 upregulation indicates better prognosis in younger acute myeloid leukemia patients undergoing chemotherapy.
    Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Hu K; Ke X; Fu L
    Oncol Lett; 2019 Jun; 17(6):5793-5802. PubMed ID: 31186806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia.
    Cheng Z; Dai Y; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Cui L; Qian T; Deng C; Fu L; Liu Y; Zeng T
    Front Oncol; 2020; 10():553344. PubMed ID: 33680910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of miR-338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy.
    Fu L; Qi J; Gao X; Zhang N; Zhang H; Wang R; Xu L; Yao Y; Niu M; Xu K
    J Cell Physiol; 2019 Nov; 234(11):20704-20712. PubMed ID: 30997674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
    Liu Y; Cao Y; Yang X; Chen H; Yang H; Liu Y; Gu W
    Transl Cancer Res; 2023 Apr; 12(4):913-927. PubMed ID: 37180663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of MiR-98 is a good prognostic factor in acute myeloid leukemia patients treated with chemotherapy alone.
    Hu N; Cheng Z; Pang Y; Zhao H; Chen L; Wang C; Qin T; Li Q; Han Y; Shi J; Fu L
    J Cancer; 2019; 10(1):178-185. PubMed ID: 30662538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Cheng Z; Zhou L; Hu K; Dai Y; Pang Y; Zhao H; Wu S; Qin T; Han Y; Hu N; Chen L; Wang C; Zhang Y; Wu D; Ke X; Shi J; Fu L
    Bone Marrow Transplant; 2018 Sep; 53(9):1089-1095. PubMed ID: 29515250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia patient with
    Huang Y; Hu J; Lu T; Luo Y; Shi J; Wu W; Han X; Zheng W; He J; Cai Z; Wei G; Huang H; Sun J
    Cancer Manag Res; 2019; 11():4129-4142. PubMed ID: 31190985
    [No Abstract]   [Full Text] [Related]  

  • 12. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Li XX; Guo H; Wen XM; Zhang W; Yang L; Liu XH; Lin J; Qian J
    Diagn Pathol; 2019 Jun; 14(1):68. PubMed ID: 31253168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
    Zhang G; Shi J; Yang X; Zhang X; Zhang L; Zhang J; Yang S; Wang J; Hu K; Ke X; Fu L
    Oncol Lett; 2019 Jun; 17(6):5815-5820. PubMed ID: 31186809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
    Ikegawa S; Doki N; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe D; Hagino T; Yoshioka K; Watakabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Pathol Oncol Res; 2017 Apr; 23(2):433-437. PubMed ID: 28004352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia.
    Yang SH; Liu W; Peng J; Xu YJ; Liu YF; Li Y; Peng MY; Ou-Yang Z; Chen C; Liu EY
    J Cancer; 2021; 12(14):4229-4239. PubMed ID: 34093823
    [No Abstract]   [Full Text] [Related]  

  • 17. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
    Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
    Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
    Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis.
    Zhu Y; Gao Q; Du J; Hu J; Liu X; Zhang F
    Ann Hematol; 2018 Sep; 97(9):1519-1526. PubMed ID: 29946906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
    Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
    Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.